Woori IO Sees FDA's Clarification as Boost to Noninvasive Glucose Monitoring.

Woori IO, a company developing noninvasive glucose monitoring technologies, welcomes FDA clarification on consumer wearable products, which allows the company to launch consumer-grade solutions while continuing to develop medical-grade systems. The clarification enables Woori IO to accelerate its time-to-market and align with its phased commercial strategy and global partnerships.